Structurally analogous trehalose and sucrose glycopolymers – comparative characterization and evaluation of their effects on insulin fibrillation

文献信息

发布日期 2022-03-07
DOI 10.1039/D1PY01517F
影响因子 5.582
作者

Andrzej Milewski, Martina H. Stenzel


查看原文

摘要

Recently, trehalose glycopolymers have been studied extensively in the context of various protein-related applications and have demonstrated some extraordinary properties. However, to fully verify their superior potential or elucidate the mechanism of their exceptional action, a relevant structural analogue is required for comparisons. The present study describes a method for synthesizing well-defined, highly structurally similar, and disaccharide-rich glycopolymers comprising trehalose and sucrose. Importantly, these glycopolymers are characterized by very low contents of non-saccharide structural fragments, which ensures that their properties are strongly dominated by the saccharide moieties. This report details the comprehensive comparative characterization of the glycopolymer analogues, including their tendency to self-assemble, their hydrolytic stabilities across a wide range of pH, and their potential susceptibilities to enzymatic hydrolysis by the corresponding glycosyl hydrolases. Additionally, the potential biorecognition of trehalose and sucrose glycopolymers through their terminal α-D-glucopyranosyl moieties is preliminarily assessed by testing their binding affinity toward the model lectin, Concanavalin A. Finally, the trehalose and sucrose glycopolymers are tested as inhibitors of amyloid fibrillogenesis, and their effects on human recombinant insulin fibrillation are thoroughly compared. This comparison reveals whether the inhibition activity is dependent on the disaccharide structure and whether trehalose glycopolymers exhibit any particularly superior anti-amyloidogenic properties.

相关文献

Atomic force microscopy study of the growth mechanism of gibbsite crystals

Sawsan J. Freij, Gordon M. Parkinson, Manijeh M. Reyhani

2004-01-27 Paper

DOI: 10.1039/B312505J

Quantifying lateral adsorbate interactions by kinetic Monte-Carlo simulations and density-functional theory: NO dissociation on Rh(100)

A. P. van Bavel, C. G. M. Hermse, M. J. P. Hopstaken, A. P. J. Jansen, J. J. Lukkien, J. W. Niemantsverdriet

2004-03-09 Paper

DOI: 10.1039/B314944G

Effect of Ru surface composition on the CO tolerance of Ru modified carbon supported Pt catalysts

E. M. Crabb, M. K. Ravikumar, D. Thompsett, M. Hurford, A. Rose, A. E. Russell

2004-03-04 Paper

DOI: 10.1039/B401641F

Calculations of interaction energies of ellipticine derivatives with DNA base pairs

Martin Dračínský, Obis Castaño

2004-03-03 Paper

DOI: 10.1039/B400471J

Effect of translational energy on the reaction Li + HF(v = 0) → LiF + H

O. Höbel, R. Bobbenkamp, A. Paladini, A. Russo, H. J. Loesch

2004-03-18 Paper

DOI: 10.1039/B400926F

Accurate equation of state of the hard sphere fluid in stable and metastable regions

Jiří Kolafa, Stanislav Labík, Anatol Malijevský

2004-04-06 Paper

DOI: 10.1039/B402792B

ATR-FTIR spectroscopic studies on aqueous LiClO4, NaClO4, and Mg(ClO4)2 solutions

Yun-Hong Zhang, Li-Jun Zhao

2003-12-17 Paper

DOI: 10.1039/B311768E

Electrospray ionisation mass spectrometry analysis of differential turnover of phosphatidylcholine by human blood leukocytes

Anthony D. Postle, Jackie Madden, Graeme T. Clark, Sarah M. Wright

2004-01-26 Paper

DOI: 10.1039/B312196H

您可能还喜欢

化合物问答

3 - (二氟甲基)-1 -氟苯(CAS号:26029-52-7)适用哪些法规指南?

3 - (二氟甲基)-1 -氟苯需遵循联合国全球化学品统一分类和标签制度(GHS),包括急性毒性、皮肤腐蚀/刺激、严重眼损伤/眼刺激等分类。同时,该化合物还需符...

26029-52-71-(Difluoromethyl)-3...
化合物问答

3,5-二甲基苯胺(CAS号:108-69-0)通常如何合成?

3,5-二甲基苯胺通常通过乙苯的氨解反应合成。反应中使用硫酸作为催化剂,反应温度为120-130°C。乙苯在硫酸存在下与氨反应,生成3,5-二甲基苯胺和苯胺副产...

108-69-03,5-Dimethylaniline
化合物问答

3-甲基异噻唑-5-胺(CAS号:24340-76-9)安全吗?

3-甲基异噻唑-5-胺在适当使用和储存条件下是相对安全的,但在操作时应注意防护措施。应避免吸入粉尘,避免与皮肤和眼睛直接接触。在操作过程中,应穿戴适当的防护装备...

24340-76-93-Methyl-1,2-thiazol...
化合物问答

3-(1,3-Thiazol-2-yl)-1H-indole(CAS号:135531-86-1)通常如何合成?

3-(1,3-噻唑-2-基)-1H-吲哚通常通过多步合成方法制备。首先,由噻唑-2-基溴化物和吲哚进行偶联反应,得到中间体。然后,通过还原反应将中间体转化为所需...

135531-86-13-(1,3-Thiazol-2-yl)...
化合物问答

4-溴-2-氟苯甲基氯(CAS号:85510-82-3)的主要用途是什么?

4-溴-2-氟苯甲基氯主要用于有机合成中间体,特别是在医药、农药和染料等领域。作为一种具有特定结构的化合物,它在合成复杂有机分子时扮演重要角色。

85510-82-34-Bromo-1-(chloromet...
化合物问答

处理Fmoc-β-(3-噻吩基)-D-Ala-OH(CAS号:220497-90-5)时应注意哪些实验室安全事项?

处理Fmoc-β-(3-噻吩基)-D-Ala-OH时,应佩戴防护手套、护目镜和实验服。操作应在通风橱内进行。如发生泄露,应立即用大量水冲洗,并通知实验室管理人员...

220497-90-5N-[(9H-Fluoren-9-ylm...
化合物问答

氮化硅(CAS号:12033-89-5)通常如何合成?

氮化硅通常通过氮化硅的直接反应合成,即在高温下将四氯化硅与氨气反应。具体步骤是将四氯化硅和氨气混合并加热至1300-1700℃,在该条件下,四氯化硅与氨气反应生...

12033-89-5Trisilicon tetranitr...
化合物问答

Cetirizine EP Impurity B DiHCl(CAS号:1000690-91-4)通常如何合成?

Cetirizine EP Impurity B DiHCl通常通过一锅法合成,首先将4-氯苯基-苯甲基氯甲酸酯与1-哌嗪乙酸反应,生成相应的酸,然后与盐酸反应...

1000690-91-4{4-[(4-Chlorophenyl)...
化合物问答

如何储存1-哌啶-4-基丁-1-酮(CAS号:3509-15-7)?

1-哌啶-4-基丁-1-酮应储存在阴凉、干燥的地方,避免阳光直射。存储容器应密封,并确保通风良好。建议储存温度不超过25℃,湿度保持在相对较低的水平。

3509-15-71-Piperidin-4-ylbuta...
化合物问答

如何处理含有VORUCICLIB(CAS号:1000023-04-0)的废料?

含有VORUCICLIB的废料应进行专业的收集和处理,包括使用适当的容器进行隔离,避免与其他化学品接触。处理方法通常包括化学中和、沉淀反应或吸附过程,随后进行焚...

1000023-04-02-[2-Chloro-4-(trifl...

来源期刊

Polymer Chemistry

Polymer Chemistry
CiteScore: 8.6
自引率: 7.3%
年发文量: 457

Polymer Chemistry welcomes submissions in all areas of polymer science that have a strong focus on macromolecular chemistry. Manuscripts may cover a broad range of fields, yet no direct application focus is required.

推荐供应商

免责声明
本页面提供的学术期刊信息仅供参考和研究使用。我们与任何期刊出版商均无关联,也不处理投稿事宜。如有投稿相关咨询,请直接联系相关期刊出版商。
如发现页面信息有误,请发送邮件至 support@chemtradehub.com 联系我们。我们将及时核实并处理您的问题。